Medpace Holdings (FRA:01P) Additional Paid-In Capital : €749 Mil(As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Medpace Holdings Additional Paid-In Capital?

Medpace Holdings's quarterly additional paid-in capital declined from Sep. 2023 (€746 Mil) to Dec. 2023 (€736 Mil) but then increased from Dec. 2023 (€736 Mil) to Mar. 2024 (€749 Mil).

Medpace Holdings's annual additional paid-in capital increased from Dec. 2021 (€644 Mil) to Dec. 2022 (€728 Mil) and increased from Dec. 2022 (€728 Mil) to Dec. 2023 (€736 Mil).

Medpace Holdings Additional Paid-In Capital Historical Data

The historical data trend for Medpace Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medpace Holdings Additional Paid-In Capital Chart

Medpace Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

599.93

572.03

644.15

727.63

736.06

Medpace Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															727.30	724.83	745.85	736.06	749.48

Medpace Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Medpace Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Medpace Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Medpace Holdings (FRA:01P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (FRA:01P) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

MEDP:USA MEDP:Mexico 01P:Germany

Address

5375 Medpace Way, Cincinnati, OH, USA, 45227

Website

https://www.medpace.com

Medpace is a late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device firms. Medpace also offers ancillary services such as bio-analytical laboratory services and imaging capabilities. The company was founded over 30 years ago, and it has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are principally based in the U.S., but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in February 2014, and it exited Medpace in August 2018.

Medpace Holdings (FRA:01P) Headlines

No Headlines